Income statement, balance sheet and cash flow statement for the last 2 fiscal years, taken from the XBRL data Ambiq Micro, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2025
FY2025
Revenue
76.1
72.5
Cost of revenue
51.8
40.4
Gross profit
24.3
32.1
Research and development
37.2
38.5
Selling, general and administrative
27.7
33.2
Operating expenses
64.9
71.6
Operating income
-40.6
-39.5
Other non-operating income
0.98
3.12
Pre-tax income
-39.6
-36.4
Income tax
0.03
0.04
Net income
-39.7
-36.5
EBITDA
-34.4
-32.3
EPS, basic
-113.50
-4.57
EPS, diluted
-113.50
-4.57
Shares, basic (weighted)
0.37
7.98
Shares, diluted (weighted)
0.37
7.98
Balance sheet
FY2025
FY2025
Cash and equivalents
61
140
Receivables
10.4
7.29
Inventory
15
16.9
Other current assets
2.57
3.42
Total current assets
89
168
Property, plant and equipment
2.62
4.14
Lease right-of-use assets
0.93
0.64
Intangible assets
11.7
11.6
Other non-current assets
0.05
0.39
Total assets
104
185
Accounts payable
2.93
8.58
Accrued liabilities
8.2
10.2
Total current liabilities
11.8
19.2
Lease liabilities
0.33
0.28
Other non-current liabilities
6.32
2.77
Total liabilities
18.5
22.2
Paid-in capital
28.4
520
Retained earnings
-320
-357
Other comprehensive income
-0.52
-0.44
Shareholders' equity
-292
162
Total equity
-292
162
Total liabilities and equity
104
185
Shares outstanding
0.43
18.3
Cash flow statement
FY2025
FY2025
Net income
-39.7
-36.5
Depreciation and amortization
6.25
7.22
Stock-based compensation
5.17
6.84
Deferred income tax
0
0
Change in receivables
1.75
3.23
Change in inventory
6.04
-2.13
Change in payables
0.82
2.86
Cash from operations
-21.4
-19.7
Cash from investing
-3.73
-7.44
Stock issued
0
103
Cash from financing
58.8
106
Net change in cash
33.7
79.3
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $69.79 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
43.6%
Gross profit / revenue.
Operating margin
-43.3%
Operating income / revenue.
EBITDA margin
-36.3%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-37.7%
Pre-tax income / revenue.
Net margin
-37.8%
Net income / revenue.
Operating cash flow margin
-30.5%
Cash from operations / revenue.
Return on equity (ROE)
-9.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-8.5%
Net income / average total assets.
Return on invested capital (ROIC)
-88.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
48.9%
Research and development expense / revenue.
SG&A / revenue
38.1%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
12.4%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
7.1%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-4.7%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
32.1%
Gross profit vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
77.1%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
2,036.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
16.0x
Current assets / current liabilities.
Quick ratio
14.7x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
14.0x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.70
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$4.50
Revenue / diluted weighted shares.
Operating cash flow per share
-$1.37
Cash from operations / diluted weighted shares.
Book value per share
$16.76
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
17.2x
Market cap / revenue.
P/B
4.17x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
4.17x
Market cap / tangible book value, when positive.
EV/Sales
13.5x
Enterprise value / revenue.
Earnings yield
-2.2%
Net income / market cap (the inverse of P/E).
What was Ambiq Micro, Inc.'s revenue in fiscal 2025?
Ambiq Micro, Inc. reported revenue of $72.5M for fiscal 2025, 4.7% lower than the year before.
Was Ambiq Micro, Inc. profitable in fiscal 2025?
No. It reported a net loss of $36.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.